Company Filing History:
3 out of 979 
3 out of 15,572 
Years Active: 2012-2018
Title: Christine E McLaren: Innovator in Cancer Diagnosis and Treatment
Introduction
Christine E McLaren is a prominent inventor based in Irvine, CA (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. With a total of 3 patents, her work focuses on innovative methods that enhance patient care and treatment options.
Latest Patents
One of her latest patents is centered on carcinoma diagnosis and treatment based on the ODC1 genotype. This invention provides methods and kits for predicting colorectal cancer patient survival, as well as the survival of patients with other invasive cancers linked to high levels of ODC activity and increased cellular polyamine contents. Additionally, it offers a means to select appropriate treatment options based on the allelic nucleotide sequence or SNP at position +316 of the ODC1 promoter gene. This approach guides treatment selection by determining the ODC1 promoter +316 position genotype.
Career Highlights
Christine has worked at esteemed institutions such as the University of Arizona and the University of California. Her research has been pivotal in advancing the understanding of cancer biology and improving therapeutic strategies.
Collaborations
Throughout her career, Christine has collaborated with notable professionals in her field, including Eugene W Gerner and Jason A Zell. These partnerships have further enriched her research and contributed to her innovative work.
Conclusion
Christine E McLaren stands out as a dedicated inventor whose work in cancer diagnosis and treatment has the potential to significantly impact patient outcomes. Her innovative approaches and collaborations highlight her commitment to advancing medical science.